3//SEC Filing
GOLDMAN SACHS & CO. LLC 3
Accession 0001209191-23-052355
CIK 0000811240other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 5:25 PM ET
Size
6.9 KB
Accession
0001209191-23-052355
Insider Transaction Report
Form 3
BIOLASE, INCBIOL
GOLDMAN SACHS GROUP INC
10% Owner
Holdings
- 144,501(indirect: See footnote)
Common Stock
GOLDMAN SACHS & CO
10% Owner
Holdings
- 144,501(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group") and Goldman Sachs & Co. LLC ("Goldman Sachs" and together with GS Group, the "Reporting Persons"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. On September 28, 2023, the Reporting Persons experienced an increase in their beneficial ownership of Biolase, Inc. (the "Issuer") to above 10% of the outstanding Common Stock. On September 29, 2023, the Reporting Persons experienced a decrease in their beneficial ownership that reduced their beneficial ownership to below 10% of the Issuer's outstanding Common Stock due to a reduction in excess securities borrows.
- [F2]The Common Stock of the Issuer reported herein as indirectly purchased were beneficially owned directly by Goldman Sachs and indirectly by GS Group.
Documents
Issuer
BIOLASE, INC
CIK 0000811240
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0000769993
Filing Metadata
- Form type
- 3
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 5:25 PM ET
- Size
- 6.9 KB